Lemon Bottle
Typical Dosing Protocols (Research/Compounded Use Only) Dosing Protocols (Research/Investigational)
Bottle is a South Korean-made injectable lipolytic (fat-dissolving) solution that has gained significant popularity on social media for non-surgical body contouring. It is marketed as a "natural" alternative to traditional fat-dissolving injections like Kybella or Aqualyx.
What It Contains
Lemon Bottle's exact formula is proprietary, but manufacturers list the key active ingredients as:
Bromelain — a proteolytic enzyme from pineapple stems (claimed to break down proteins and aid fat metabolism).
Riboflavin (Vitamin B2) — supports metabolic processes.
Lecithin — a phospholipid that acts as an emulsifier to help break down fat cell membranes.
Sometimes additional plant extracts or caffeine.
It does not contain deoxycholic acid (the active ingredient in FDA-approved Kybella).
Claimed Benefits
Reduces localized stubborn fat pockets (e.g., double chin, abdomen, flanks, thighs, arms, back).
Promotes lipolysis (fat breakdown) and lymphatic drainage so the body can eliminate the fat naturally.
Faster visible results and less swelling/pain compared to deoxycholic acid-based products (per marketing and some user reports).
Minimal downtime, with claims of "gentler" treatment.
Sessions typically involve multiple small injections into the target area, with 1–3+ treatments spaced weeks apart depending on the area and desired result. It is promoted for small-to-moderate fat deposits, not overall weight loss.
Important Reality Check (Safety & Evidence)
Not FDA-approved — The U.S. FDA has issued warning letters to sellers and platforms (including Amazon) regarding Lemon Bottle and similar unapproved injectable lipolytic products. These are considered unapproved new drugs, and their safety, quality, and efficacy have not been evaluated by the FDA.
Limited clinical evidence — There are no large, robust, peer-reviewed clinical trials demonstrating consistent, long-term effectiveness or safety. Most claims rely on manufacturer data, small observations, or anecdotal reports. Results are highly variable.
Regulatory concerns — In the UK and Europe, it lacks MHRA approval or CE marking for medical use in many contexts. Regulatory bodies have raised alarms about unregulated cosmetic injectables, inconsistent ingredient quality, and potential for serious harm.
Variable outcomes — Some users report noticeable fat reduction with minimal side effects; others experience little to no change, uneven results, or prolonged swelling.
